Matching slides 11,406
Current window 7,831-7,860
Pages 381
Rows per page 30
Component: Subtitleclear collectionreset all

Component

7,831-7,860 of 11,406

filter-aware
09
The slide uses a split-layout with a narrative on the left and a list of strategic pillars on the right.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The table provides a reconciliation of earnings excluding notable items, with a footnote explaining the change in reporting methodology starting Q4 2023.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
24
Includes detailed footnotes regarding ADIP ownership and retroactive adjustments.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
30
Includes detailed footnotes explaining specific line items like equity-based profit sharing and transaction-related charges.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
19
The table highlights the performance of various business segments, with Wines & Spirits being the only one showing a decline.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
20
The chart displays quarterly performance (Q1-Q4) and full-year 2023 for six business segments.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
22
The table shows revenue, margins, expenses, and profit metrics with year-over-year percentage changes.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
26
The table breaks down cash flow from operations, net cash from operating activities, and operating free cash flow.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
27
The chart combines a bar chart for debt (in millions of euros) and a line chart for the gearing percentage.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
11
The slide outlines a multi-part clinical trial process from Part A (Safety) through Part B (Efficacy/Dose Selection) to a planned Expansion phase.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
The slide outlines a multi-part clinical trial design (basket/umbrella) for a biotech drug candidate.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
22
The slide outlines a clinical trial process flow involving SCLC and NSCLC patient baskets, immune activation, and subsequent combination therapies leading to a Phase 3 expansion.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
29
Includes a footnote referencing page 30 for additional Warehouse information.New York Community Bancorp | Results Presentation Deck | 42 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Solution1 hit
35
Includes SBNY acquisition impact and prior acquisitions.New York Community Bancorp | Results Presentation Deck | 42 slides · New York Community Bancorp
Conference presentation Investor relations 1 hit
12
Slide 12 of the deck.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations Beat · ProductLoop · Mece Breakdown1 hit
40
The slide uses three distinct chart types to demonstrate superiority in three key pharmacological areas.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
01
Slide 1
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
24
The slide uses a chevron-based list layout to categorize key highlights.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
25
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
09
The chart shows a clear downward trend in medical costs for all cohorts compared to the rising benchmark.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
18
The table includes adjustments for non-cash items like goodwill impairment and stock-based compensation.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
06
The slide uses a consistent color scheme (light blue for Q1 2023, dark blue for Q1 2024) and percentage change callouts for each metric.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a numbered list format to present financial assumptions.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Golden Circle1 hit
12
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
05
The table includes GAAP and non-GAAP metrics, with a year-over-year (YoY) change column for 2023.Tesla | Results Presentation Deck | 32 slides · Tesla
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
30
Contains four distinct sub-tables: quarterly FCF, quarterly EBITDA, TTM FCF, and TTM EBITDA.Tesla | Results Presentation Deck | 32 slides · Tesla
Conference presentation Investor relations 1 hit
27
Reconciliation Tables /1Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
28
Reconciliation Tables /2Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
29
Includes footnotes defining regional compositions.Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
30
Reconciliation Tables/1Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit